ArticleBMC genomics2025
Evolutionary diversification and expressional profile of adrenergic receptors in the Pacific oyster Crassostrea gigas.
Article in BMC genomics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundAdrenergic receptors (ARs) specifically recognize and bind catecholamines via conserved seven-transmembrane G protein-coupled receptor (GPCR) domains, which are regarded as critical mediators of immune responses in molluscan species.
resultsIn the present study, six ARs were identified in the Pacific oyster Crassostrea gigas, which exhibited conserved structural features of G protein-coupled receptors (GPCRs that were characterized by seven transmembrane helices (TM1-TM7) and a DR(Y) motif within the third intracellular loop. These receptors were classified into two subfamilies: α-type (Cgα1A, Cgα2A, Cgα2C, Cgα2Da, and Cgα2Db-ARs) and β-type (Cgβ2-AR). Notably, evolutionary divergence between the Cgα2Da and Cgα2Db subtypes has led to the absence of their orthologs in most vertebrate species. Both subtypes (Cgα2Da and Cgα2Db) are under relaxed purifying selection (Ka/Ks = 0.644 and 0.828, respectively). Transcriptomic profiling revealed distinct spatiotemporal expression patterns, with Cgα2A-AR, Cgα2C-AR, and Cgα2Da-AR predominantly expressed in hemocytes. Among them, Cgα2C-AR and Cgα2Da-AR were enriched in granulocytes, whereas Cgα2A-AR was preferentially expressed in agranulocytes. Moreover, transcripts of Cgα2A-AR, Cgα2C-AR, and Cgβ2-AR in hemocytes increased significantly following the first Vibrio splendidus stimulation, with Cgα2A-AR exhibiting a significant increase again after the secondary stimulation.
conclusionsCollectively, these results suggested that the retention of Cgα2Da/α2Db-AR subtypes in oysters under relaxed selection pressure reflects an evolutionary strategy for immune adaptability. Their lineage-restricted diversification drives differential expression (e.g., Cgα2Da-AR in granulocytes) and post-challenge resilience (e.g., Cgα2A-AR upregulation), balancing energy conservation and pathogen defense. These findings provided a foundation for further elucidation of their immunoregulatory roles in oysters and contribute to an improved understanding of AR evolution in invertebrates.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.